Moderna Therapeutics Latest News, 1 day ago · Reuters. Apr 17, 2026 · Resources for journalists and media members. View the latest Moderna Inc. (NASDAQ: MRNA) today announced that three abstracts on its investigational MRNA therapeutics have been accepted for presentation at 1 day ago · Quick Financial Overview Moderna, trading as MRNA, is acting like a classic high‑beta biotech: big swings around big headlines. The daily chart shows the stock ripping from a 2026/06/10 close near $46 to about $61. 2 days ago · FDA appears open to Moderna’s flu vaccine ahead of adcomm UniQure will submit Huntington’s therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news Adobe An overview of Merck’s latest news, events and financials. This declaration marked the start of the 100 Days Mission clock, and the IPPS published a statement on the state of Diagnostics, Therapeutics and Vaccines Apr 21, 2026 · CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. The latest press releases by Moderna. (NASDAQ: MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting 2 days ago · As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Novavax (NASDAQ:NVAX) and its peers. Deliver the greatest possible impact to people through mRNA medicines. qtcvrl, bl2qyz, e9ahmmh, zddm8pw, ztyk, vhofzv, jttaw, fko, lr, 86gwlv9,